NASDAQ

Kymera Therapeutics, Inc. (KYMR)

♥ 511 Thanks from members

Live price chart, market sentiment, and community perspectives for Kymera Therapeutics, Inc. (NASDAQ: KYMR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Alexey NesvizhskiiFounder: Nathanael GrayLeadership: Neil Dhawan (CEO)Holder: Atlas VentureHolder: Baker Bros. AdvisorsHolder: RA Capital ManagementPeggy Targeted Protein DegradersImmunology PipelinesOncology Pipelines#KYMR#Kymera Therapeutics#Biotech#Protein Degradation#NASDAQ